| NAME OF THE PROJECT | : Lacosamide |
| PRODUCT NAME | : Lacosamide Impurity - F(Propionic Impurity) |
| CODE & CAT NO | : LP - 3100-03-004 |
| MOLECULAR FORMULA | : C14H20N2O3 |
| MOLECULAR WEIGHT | :264.32 |
| CAS NO | : 1318777-56-8 |
| CHEMICAL NAME | : 2(R)-Propionylamino-N-benzyl-3-methoxypropionamide |
| CAT NO | : LP - 3100-01-001 |
| CAS NO | : 175481-36-4 |
| Mol.F | : C13H18N2O3 |
| Mol.Wt. | : 250.3 |
| CAT NO | : LP - 3100-03-001 |
| CAS NO | : 175481-37-5 |
| Mol.F | : C13H18N2O3 |
| Mol.Wt. | : 250.3 |
| CAT NO | : LP - 3100-03-002 |
| CAS NO | : 196601-69-1 |
| Mol.F | : C11H16N2O2 |
| Mol.Wt. | : 208.26 |
| CAT NO | : LP - 3100-03-003 |
| CAS NO | : 388619-64-5 |
| Mol.F | : C14H20N2O3 |
| Mol.Wt. | : 264.3 |
| CAT NO | : LP - 3100-03-004 |
| CAS NO | : 1318777-56-8 |
| Mol.F | : C14H20N2O3 |
| Mol.Wt. | : 264.32 |
| CAT NO | : LP - 3100-03-005 |
| CAS NO | : 175481-38-6 |
| Mol.F | : C9H11NO |
| Mol.Wt. | : 149.19 |
| CAT NO | : LP - 3100-03-006 |
| CAS NO | : 4128-37-4 |
| Mol.F | : C7H16N2O |
| Mol.Wt. | : 144.21 |
| CAT NO | : LP - 3100-03-007 |
| CAS NO | : 175481-38-6 |
| Mol.F | : C12H16N2O3 |
| Mol.Wt. | : 256.7 |
| CAT NO | : LP - 3100-03-008 |
| CAS NO | : 1318777-54-6 |
| Mol.F | : C14H18N2O4 |
| Mol.Wt. | : 278.3 |
| CAT NO | : LP - 3100-03-009 |
| CAS NO | : NA |
| Mol.F | : C15H22N2O4 |
| Mol.Wt. | : 294.35 |
| CAT NO | : LP - 3100-03-010 |
| CAS NO | : NA |
| Mol.F | : C16H24N2O4 |
| Mol.Wt. | : 308.37 |
| CAT NO | : LP - 3100-03-011 |
| CAS NO | : 1318777-56-8 |
| Mol.F | : C14H20N2O3 |
| Mol.Wt. | : 264.32 |
| CAT NO | : LP - 3100-03-013 |
| CAS NO | : 175481-39-7 |
| Mol.F | : C10H14N2O2.HCl |
| Mol.Wt. | : 230.69 |
CATEGORY : Lacosamide
TOTAL PRODUCTS : 13
FILTER BY : API
Lavybens pharma's competitive advanced manufacturing facilities, R & D capabilities, extensive domestic network in Indian Pharma market and International.
Copyrights © Lavybens Pharma All rights Reserved
